6 Year Follow-Up of Balloon-Expandable Versus Self-Expanding Transcatheter Aortic Valves: A Propensity-Matched Analysis
- PMID: 40490129
- DOI: 10.1016/j.amjcard.2025.06.002
6 Year Follow-Up of Balloon-Expandable Versus Self-Expanding Transcatheter Aortic Valves: A Propensity-Matched Analysis
Abstract
Prior reports comparing long-term outcomes of balloon-expandable (BE) versus self-expanding (SE) transcatheter aortic valve implantation (TAVI) have been limited. We compared in-hospital, 1-year, and 6-year outcomes in 1,685 BE (S3, Ultra) versus 776 SE (Evolut R, PRO, PRO+) patients undergoing transfemoral TAVI at a single center. Valve-in-valve and nontransfemoral access cases were excluded. Propensity-score matched BE (n = 683) and SE (n = 680) cohorts did not differ with respect to age (82.2 ± 8.0 vs 82.1 ± 7.8 years, p = 0.407), baseline demographics and comorbidities, pre-TAVI echo and cardiac catheterization results, and STS Risk Score (7.9 ± 5.9 vs 7.9 ± 5.5%, p = 0.481). BE vs SE patients had similar in-hospital mortality (0.9 vs 0.6%, p = 0.0.072), stroke (1.3 vs 1.8%, p = 0.503), major vascular complications (2.8 vs 2.2%, p = 0.495) and composite bleeding (4.7 vs 3.4%, p = 0.178), although the BE cohort required fewer permanent pacemakers (8.3 vs 13.3%, p = 0.003). At 1-year, BE and SE patients had similar all-cause mortality (10.8 vs 11.2%, p = 0.825), hospital readmission (22.5 vs 19.6%, p = 0.192), and KCCQ12 scores (83.7 ± 25.5 vs 83.0 ± 24.6, p = 0.606). At a median follow-up of 77.0 (72.6 to 81.5) months, Kaplan-Meier survival analysis demonstrated no difference in BE vs SE all-cause mortality (33.2 vs 40.4%, p = 0.586), with no differences in late valve-related outcomes including myocardial infarction, stroke, AV endocarditis, and AV re-intervention (balloon aortic valvuloplasty, percutaneous paravalvular leak closure, repeat TAVI, surgical AV replacement). However, BE patients more commonly required treatment for subclinical leaflet thrombosis, while SE patients had a higher incidence of transient ischemic attack during follow-up. In conclusion, BE and SE TAVI patients have similar in-hospital, 1-year and median 6-year adverse outcomes, other than higher subclinical leaflet thrombosis in BE patients and an increased transient ischemic attack rate in SE patients.
Keywords: balloon-expandable valve; self-expanding valve; transcatheter aortic valve implantation.
Copyright © 2025 The Author(s). Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
